A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study-Reference-Cited by-同舟云学术

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study

Published:2009-03 Issue:3 Volume:20 Page:179-184
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lara Primo N.,Longmate Jeff,Evans Christopher P.,Quinn David I.,Twardowski Przemyslaw,Chatta Gurkamal,Posadas Edwin,Stadler Walter,Gandara David R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference30 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Clinical states in prostate cancer: toward a dynamic model of disease progression;Scher;Urology,2000

3. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer;Aprikian;Prostate? Supplement,1998

4. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma;Bostwick;Am J Surg Pathol,1994

5. Elevated plasma chromogranin-A concentrations in prostatic carcinomas;Kadmon;J Urology,1991

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Drug Repurposing: The Example of Saracatinib;International Journal of Molecular Sciences;2024-04-22

2. Resistance of prostate cancer to kinase inhibitors;Therapy Resistance in Prostate Cancer;2024

3. Src family kinases engage differential pathways for encapsulation into extracellular vesicles;Journal of Extracellular Biology;2023-06

4. Macrophages promote anti-androgen resistance in prostate cancer bone disease;Journal of Experimental Medicine;2023-02-07

5. Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders;Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders;2023